Phenotypical heterogeneity of acute myeloid leukemia in the elderly: a clue for a personalized therapy?

Acute myeloid leukemia (AML) is a disease of the elderly where only 6.7% of patients >65 years of age are alive at 5 years from diagnosis [1]. This poor prognosis is due to clinical unfitness of ol...